RECURSION PHARMACEUTICALS, INC. (RXRX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.44 | +14.8% |
| 2024 | $-1.69 | -7.0% |
| 2023 | $-1.58 | -16.2% |
| 2022 | $-1.36 | +8.7% |
| 2021 | $-1.49 | +62.7% |
| 2020 | $-3.99 | -39.0% |
| 2019 | $-2.87 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.44 | +14.8% |
| 2024 | $-1.69 | -7.0% |
| 2023 | $-1.58 | -16.2% |
| 2022 | $-1.36 | +8.7% |
| 2021 | $-1.49 | +62.7% |
| 2020 | $-3.99 | -39.0% |
| 2019 | $-2.87 | — |